HealthVerity builds the IPGE (Identity, Privacy, Governance and Exchange) platform, a unified infrastructure for discovering, accessing and applying real-world healthcare data. Its platform enables identity resolution, privacy-preserving governance and secure data exchange for life sciences, payers and government agencies. The company serves more than 250 leading healthcare enterprises and works with over 80% of top pharmaceutical companies. Over the past year it was selected by the U.S. Department of Health and Human Services to deliver Privacy Preserving Record Linkage for the COVID-19 vaccine rollout and has partnered with the FDA and NIH on COVID-19 studies. HealthVerity plans to use the new financing to accelerate go-to-market efforts and expand its real-world data ecosystem and patient identity-resolution technology. The company raised $100 million in a Series D to support these growth and product-expansion initiatives. HealthVerity operates a technology platform for creation, exchange, and management of healthcare and consumer data, emphasizing interoperability and privacy. Its product suite includes HealthVerity Census, a SaaS solution for activating, de-identifying, and linking data; HealthVerity Marketplace, a cloud platform for discovery and licensing of broad-scale healthcare and consumer data; and HealthVerity Consent, a blockchain-driven platform for managing patient and consumer permissions. The company highlights highly sophisticated identity resolution and matching capabilities to increase transparency and activate deeper insights. HealthVerity reported a record 2018 performance and expanded its customer base to more than 100 top pharmaceutical manufacturers, health insurance payers, pharmaceutical services firms, and healthcare services organizations. The new capital will support continued growth and investment in the company’s technology platform and go-to-market activities. Andrew Kress is co-founder and CEO. HealthVerity operates a cloud platform and Marketplace that enables discovery, licensing and linking of broad-scale healthcare data, offering linkable HIPAA-compliant de-identified data on more than 300 million U.S. individuals from over thirty national suppliers. Its data types include medical claims, prescription claims, lab results, electronic medical records and other significant data, and the platform provides self-service tools to build custom datasets, identify patient counts and explore longitudinality across sources. The Marketplace supports simplified data licensing to streamline access for advanced analytics and real-world evidence. HealthVerity reports traction with leading pharmaceutical companies and serves pharmaceutical manufacturers, provider and payer customers. The company plans to use its new financing to expand its healthcare data ecosystem, advance privacy solutions and further develop proven data interoperability technologies. HealthVerity is based in Philadelphia and is led by co-founder and CEO Andrew Kress. HealthVerity provides technologies and software tools for the discovery and integration of optimal patient data sets. The company focuses on four key areas: Patient Intelligence, Geodirected Solutions, Smart Media and Social Informatics. It said it will use recent funding to accelerate development of its privacy and data interoperability technologies. CEO Andrew Kress described the company's work as addressing challenges facing healthcare providers who are awash in clinical and transactional data but struggle to unlock the value of those assets. HealthVerity's solutions aim to empower customers to extract new insights with a more novel, intuitive and efficient approach to building data sets for research and analytics. The company's website does not provide detailed information on the platform's technical approach or the specific technologies used to extract value from patient data.

Total raised

$142M

Funding rounds

4

Latest round

Series D

Latest activity

Jun 2021